Manhattan Research Report Explores Online Adherence Opportunities

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research releases its latest consumer marketing research module, "Online Adherence Programs: Evaluating Manufacturers' Opportunity to Impact Patient Adherence", as part of its Cybercitizen Health™ market research and strategic advisory service.

The objective of the Online Adherence Module is to provide pharma, biotech, and device marketers with the necessary data and insights to develop their online adherence strategy to increase sales in the face of shrinking pipelines and expiring patents. It gives an in-depth look at the role the Internet plays in how consumers adhere to treatment today, the outlook for consumer demand for online adherence services in the mid-term, and best practices for manufacturers.

According to the analysis, emerging technology, consumer adoption of new media, and an increasing culture of self-service, among other factors, has put the Internet in a prime position to significantly affect patient adherence, treatment outcomes, and ultimately the manufacturer's bottom line. But along with the opportunities come numerous challenges, especially among certain therapeutic segments, requiring manufacturers implement best practices from the get go.

"Successful adherence programs can greatly benefit manufacturers, as relatively small changes in patient behavior have the potential to substantially increase revenue," said Monique Levy, author of the analysis and Senior Director of Research at Manhattan Research. "Though manufacturers have been somewhat reluctant to put all of their weight behind these types of initiatives in the past due to complexity and cost, digital channels are offering new and effective ways to facilitate patient adherence."

Analysis Outline
Title: Online Adherence Programs: Evaluating Manufacturers' Opportunity to Impact Patient Adherence

Introduction

I. Role of the Internet on Treatment Adherence

Figure 1-1: Adoption of Dedicated Adherence Online Resources

Figure 1-2: Occasions When Consumers Perform Online Health Research

Figure 1-3: Shifts in the Digital Health Media Landscape

Figure 1-4: Adoption of Dedicated Adherence Resources Across Select Therapeutic Segments

Figure 1-5: Occasions in Which Consumers in Different Therapeutic Categories go Online for Health Information

II. Consumer Demand for Online Adherence Resources in the Mid-term

Figure 2-1: Interest in Prescription Refill Reminders

Figure 2-2: Interest in Prescription Refill Reminders Among Online Consumers Who Take Prescription Drugs Across Select Conditions

Figure 2-3: Demand for Health Services on Mobile Devices

Figure 2-4: ePharma Consumer Using or Very Interested in Accessing Information about Prescription Drugs on General Health Sites

Figure 2-5: Drivers and Inhibitors of Online Adherence

Close-up 2-1: Johnson & Johnson’s CareConnect iPhone App

III. Best Practices for Manufacturers

Key Learnings and Action Items

For an excerpt from the module and more information about its contents, please visit: http://www.manhattanresearch.com/products/Research_Modules/Consumer/online-patient-adherence.aspx.

Access to the "Online Adherence Programs" research module is immediately available to subscribers of Manhattan Research's Cybercitizen Health™ market research and strategic advisory service. For more information about becoming a subscriber to this service and gaining access to the in-depth consumer market data and analysis, visit http://www.manhattanresearch.com/cch.

About Cybercitizen Health™ v8.0
Cybercitizen Health™ v8.0 was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). This consumer market research and strategic advisory service focuses on how consumers use new media and technology for health and its impact on treatment and product decisions. For topics and available therapeutic segmentations (100+), please visit http://www.manhattanresearch.com/cch.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...